Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 1, 2009, Pages 23-30

  Yuan, Haodan ^a   Feng, Bo ^a   Yu, Ying ^a   Chupka, Jonathan ^a   Zheng, Jenny Y ^a   Heath, Timothy G ^a   Bond, Brian R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CI 1027; FIBRIC ACID DERIVATIVE; GEMCABENE; GEMCABENE ACYLGLUCURONIDE; ORGANIC ANION TRANSPORTER 3; QUINAPRIL; QUINAPRILAT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOADING DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 67649886935     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.150870     Document Type: Article

References (20)

1. Bauman JN, Goosen TC, Tugnait M, Peterkin V, Hurst SI, Menning LC, Milad M, Court MH, and Williams JA (2005) UDP-glucuronosyltransferase 2b7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomes. Drug Metab Dispos 33:1349-1354. (Pubitemid 41196978)
2. Bays H and Stein EA (2003) Pharmacotherapy for dyslipidaemia-current therapies and future agents. Expert Opin Pharmacother 4:1901-1938. (Pubitemid 37408104)
3. Burckhardt BC, Brai S, Wallis S, Krick W, Wolff NA, and Burckhardt G (2003) Transport of cimetidine by flounder and human renal organic anion transporter 1. Am J Physiol Renal Physiol 284:F503-F509. (Pubitemid 36227911)
4. Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, and Endou H (2001) Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 59:1277-1286. (Pubitemid 32385197)
5. DeFelice EA and Kostis JB (1987) Angiotension Converting Enzyme Inhibitors, Alan R. Liss, Inc., New York.
6. Dresser MJ, Leabman MK, and Giacomini KM (2001) Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci 90:397-421. (Pubitemid 32298045)
7. Feng B, Obach RS, Burstein AH, Clark DJ, de Morais SM, and Faessel HM (2008) Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study. Clin Pharmacol Ther 83:567-576.
8. Hasegawa M, Kusuhara H, Sugiyama D, Ito K, Ueda S, Endou H, and Sugiyama Y (2002) Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. J Pharmacol Exp Ther 300:746-753. (Pubitemid 34164975)
9. Kaplan HR, Taylor DG, Olson SC, and Andrews LK (1989) Quinapril-a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology 40:335-350. (Pubitemid 19108868)
10. Kugler AR, Olson SC, and Smith DE (1995) Disposition of quinapril and quinaprilat in the isolated perfused rat kidney. J Pharmacokinet Biopharm 23:287-305.
11. Kugler AR, Olson SC, and Smith DE (1996) Tubular transport mechanisms of quinapril and quinaprilat in the isolated perfused rat kidney: effect of organic anions and cations. J Pharmacokinet Biopharm 24:349-368.
12. Nakagomi-Hagihara R, Nakai D, and Tokui T (2007) Inhibition of human organic anion transporter 3 mediated pravastatin transport by gemfibrozil and the metabolites in humans. Xenobiotica 37:416-426. (Pubitemid 46572887)
13. Olson SC, Horvath AM, Michniewicz BM, Sedman AJ, Colburn WA, and Welling PG (1989) The clinical pharmacokinetics of quinapril. Angiology 40:351-359.
14. Race JE, Grassl SM, Williams WJ, and Holtzman EJ (1999) Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3). Biochem Biophys Res Commun 255:508-514. (Pubitemid 29292290)
15. Tahara H, Kusuhara H, Maeda K, Koepsell H, Fuse E, and Sugiyama Y (2006) Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid. Drug Metab Dispos 34:743-747.
16. Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K, and Endou H (1999) Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 10:464-471. (Pubitemid 29117627)
17. Uwai Y, Okuda M, Takami K, Hashimoto Y, and Inui K (1998) Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney. FEBS Lett 438:321-324. (Pubitemid 28529298)
18. Uwai Y, Saito H, and Inui K (2000) Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter. Eur J Pharmacol 409:31-36. (Pubitemid 30950633)
19. Wadworth AN and Brogden RN (1991) Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders. Drugs 41:378-399. (Pubitemid 21920735)
20. Wright SH and Dantzler WH (2004) Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84:987-1049. (Pubitemid 38823772)